Europe Markets
OpenAI Resolves Leadership Drama as Sam Altman Returns, Microsoft Emerges Victorious
Sam Altman has returned to OpenAI after a tumultuous five days of uncertainty and speculation. Altman, the co-founder of the renowned artificial intelligence research laboratory,...
Oil Prices Decline 4% as OPEC+ Meeting Faces Unexpected Delay
Oil prices experienced a significant 4% decline on Wednesday following an unexpected delay in the scheduled OPEC+ ministerial meeting. The meeting, originally slated for Sunday,...
Stocks Show Gains Amidst Nvidia Earnings and AI Drama
In the early hours of Wednesday, stocks experienced modest gains as investors processed the quarterly earnings report from artificial intelligence chipmaker Nvidia (NVDA) ahead of...
Stocks Take a Breather in November Rally, Eyes on Nvidia and Fed Minutes
In a session marked by a notable retreat, stocks concluded lower on Tuesday, indicating a temporary halt in the robust November rally. Investors braced themselves...
LQR House Board Approves 60:1 Reverse Stock Split , Stock Dips
LQR House Inc, a pioneering liquor marketing company known for its dynamic and forward-thinking approach, made a strategic announcement today regarding a substantial change in...
ADDvantage Technologies Group Stock Surges Following Reverse Stock Split and Q3 Results
In a remarkable turn of events on Tuesday, the stock of ADDvantage Technologies Group Inc, a prominent communications infrastructure services and equipment provider, experienced a...
Anghami and OSN+ Announce Groundbreaking Merger, Stock Rises
In a landmark move set to redefine the media and entertainment landscape in the Middle East and North Africa (MENA) region, Anghami Inc, the foremost...
Polished.com Releases with Q3 2023 Results, Stock Falls 28%
In a press release issued yesterday, Polished.com Inc, an online consumer goods retailer, disclosed its financial results for the third quarter (Q3) ended September 30,...
Galmed Pharmaceuticals Delays PSC Study Initiation, Stock Dips
Galmed Pharmaceuticals Ltd, a renowned clinical-stage biopharmaceutical company specializing in liver, metabolic, and fibrotic diseases, has encountered an unexpected delay in the commencement of its...
Home Sales Decline Amid Rising Rates and Soaring Prices
In a challenging month for prospective homebuyers, the resale housing market witnessed a significant downturn as elevated mortgage rates and escalating home prices dealt a...